Lista de obras - M. Hoglund - Dominio Público Uruguay

AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and dose dependent reduction of tyrosine kinase activity in acute myeloid leukemia.

artículo científico publicado en 2013

Acute myeloid leukemia in the real world: why population-based registries are needed ⬇️

artículo científico publicado el 26 de abril de 2012

Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients.

artículo científico publicado en 2013

Administration of G-CSF to healthy subjects: the effects on eosinophil counts and mobilization of eosinophil granule proteins

artículo científico publicado en 1997

Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register

artículo científico publicado en 2016

Answer to "Letter to the Editor, Scandinavian Journal of Infectious Diseases".

artículo científico publicado en 2013

Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis.

artículo científico publicado en 2015

Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: a report from the Swedish Acute Leukemia Registry

artículo científico publicado en 2015

Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia.

artículo científico publicado en 2013

Comparable aciclovir exposures produced by oral valaciclovir and intravenous aciclovir in immunocompromised cancer patients.

artículo científico publicado en 2001

Complete molecular remission in chronic myelogenous leukemia after imatinib therapy.

artículo científico publicado en 2002

Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.

artículo científico publicado en 2011

Cryoglobulin-induced cytokine production via FcgammaRIIa: inverse effects of complement blockade on the production of TNF-alpha and IL-10. Implications for the growth of malignant B-cell clones

scientific article published on 01 June 2005

Cryoglobulins induce temperature-dependent TNF-α production via Fcγ-receptor II.

artículo científico publicado en 2002

Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia

artículo científico publicado en 2008

Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006).

artículo científico publicado en 2014

Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF

scientific article published on 01 July 1996

Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997-2013.

artículo científico publicado en 2017

Effects of in vivo administration of G-CSF on neutrophil and eosinophil adhesion.

artículo científico publicado en 1997

Effects of in vivo administration of G-CSF on neutrophil functions in healthy volunteers

artículo científico publicado en 1997

Epidemiology of chronic myeloid leukaemia: an update

artículo científico

Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia

artículo científico publicado en 2014

G- and GM-CSF in oncology and oncological haematology.

artículo científico publicado en 1994

Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)--what is the difference?

artículo científico publicado en 1998

Granulocyte colony-stimulating factor (G-CSF) induces the production of cytokines in vivo

artículo científico publicado en 2000

HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia.

artículo científico publicado en 2016

High prevalence and incidence of cardiovascular disease in chronic lymphocytic leukaemia: a nationwide population-based study

artículo científico publicado en 2020

High-dose chemotherapy with autologous stem cell support in patients with responding stage IV breast cancer

scientific article published on 01 September 1998

Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia.

artículo científico publicado en 2016

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.

artículo científico publicado en 2016

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population

artículo científico publicado en 2016

Mobilization of CD34+ cells by glycosylated and nonglycosylated G-CSF in healthy volunteers--a comparative study

scientific article published on 01 September 1997

No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: a population-based study in Sweden.

artículo científico publicado en 2017

Pregnancy and risk of acute myeloid leukaemia--a case-control study

artículo científico publicado en 2011

Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks

scientific article published on 29 September 2011

Pulmonary side effects of interferon‐α therapy in patients with hematological malignancies ⬇️

artículo científico publicado el 1 de mayo de 2003

Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib

artículo científico publicado en 2014

Reply to D. Pulte et al.

artículo científico publicado en 2016

Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.

artículo científico publicado en 2009

Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

artículo científico publicado en 2016

Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era.

artículo científico publicado en 2015

Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase

scientific article published on 01 September 2006

Successful treatment of chronic wound infection in neutropenia and rheumatoid arthritis with filgrastim (rhG-GSF)

artículo científico publicado en 1994

The effect of granulocyte colony-stimulating factor (G-CSF) on the degranulation of secondary granule proteins from human neutrophils in vivo may be indirect

scientific article published on 01 June 1996

The effect of rGM-CSF on neutrophil and eosinophil regeneration after ABMT as monitored by circulating levels of granule proteins

artículo científico publicado en 1994

The tyrosine kinase inhibitors imatinib and dasatinib reduce myeloid suppressor cells and release effector lymphocyte responses

artículo científico

Topoisomerase IIalpha expression in acute myeloid leukaemia cells that survive after exposure to daunorubicin or ara-C.

artículo científico publicado en 2009

Topoisomerase IIalpha mRNA and protein expression vs. in vitro drug resistance and clinical outcome in acute leukaemia

scientific article published on 01 July 2007

Treatment and outcome of 2904 CML patients from the EUTOS population-based registry

artículo científico publicado en 2016

Treatment of pure red-cell aplasia and aplastic anaemia with ciclosporin: long-term clinical effects.

artículo científico publicado en 1989

Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?

scientific article published on 14 October 2016

[Malignant lymphoma. Experiences with autologous bone marrow transplantation in 50 patients]

artículo científico publicado en 1993

Lista de obras de M. Hoglund

AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and dose dependent reduction of tyrosine kinase activity in acute myeloid leukemia.

Acute myeloid leukemia in the real world: why population-based registries are needed ⬇️

Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients.

Administration of G-CSF to healthy subjects: the effects on eosinophil counts and mobilization of eosinophil granule proteins

Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register

Answer to "Letter to the Editor, Scandinavian Journal of Infectious Diseases".

Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis.

Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: a report from the Swedish Acute Leukemia Registry

Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia.

Comparable aciclovir exposures produced by oral valaciclovir and intravenous aciclovir in immunocompromised cancer patients.

Complete molecular remission in chronic myelogenous leukemia after imatinib therapy.

Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.

Cryoglobulin-induced cytokine production via FcgammaRIIa: inverse effects of complement blockade on the production of TNF-alpha and IL-10. Implications for the growth of malignant B-cell clones

Cryoglobulins induce temperature-dependent TNF-α production via Fcγ-receptor II.

Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia

Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006).

Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF

Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997-2013.

Effects of in vivo administration of G-CSF on neutrophil and eosinophil adhesion.

Effects of in vivo administration of G-CSF on neutrophil functions in healthy volunteers

Epidemiology of chronic myeloid leukaemia: an update

Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia

G- and GM-CSF in oncology and oncological haematology.

Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)--what is the difference?

Granulocyte colony-stimulating factor (G-CSF) induces the production of cytokines in vivo

HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia.

High prevalence and incidence of cardiovascular disease in chronic lymphocytic leukaemia: a nationwide population-based study

High-dose chemotherapy with autologous stem cell support in patients with responding stage IV breast cancer

Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia.

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population

Mobilization of CD34+ cells by glycosylated and nonglycosylated G-CSF in healthy volunteers--a comparative study

No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: a population-based study in Sweden.

Pregnancy and risk of acute myeloid leukaemia--a case-control study

Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks

Pulmonary side effects of interferon‐α therapy in patients with hematological malignancies ⬇️

Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib

Reply to D. Pulte et al.

Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.

Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era.

Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase

Successful treatment of chronic wound infection in neutropenia and rheumatoid arthritis with filgrastim (rhG-GSF)

The effect of granulocyte colony-stimulating factor (G-CSF) on the degranulation of secondary granule proteins from human neutrophils in vivo may be indirect

The effect of rGM-CSF on neutrophil and eosinophil regeneration after ABMT as monitored by circulating levels of granule proteins

The tyrosine kinase inhibitors imatinib and dasatinib reduce myeloid suppressor cells and release effector lymphocyte responses

Topoisomerase IIalpha expression in acute myeloid leukaemia cells that survive after exposure to daunorubicin or ara-C.

Topoisomerase IIalpha mRNA and protein expression vs. in vitro drug resistance and clinical outcome in acute leukaemia

Treatment and outcome of 2904 CML patients from the EUTOS population-based registry

Treatment of pure red-cell aplasia and aplastic anaemia with ciclosporin: long-term clinical effects.

Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?

[Malignant lymphoma. Experiences with autologous bone marrow transplantation in 50 patients]